Dear Friend, More bad news from Big Pharma. Internal documents from Pfizer that were recently submitted in a lawsuit against that company showed that the pharmaceutical manufacturer tried to put a lid on medical studies that did not support the use of its epilepsy drug, Neurontin. More than that, it seems that the marketing arm of Pfizer even went so far as to delay the publication and even ALTER THE CONCLUSIONS OF STUDIES that found that the drug did not work for conditions other than epilepsy.
Pfizer is accused of doing this to boost sales – and it must've worked. Before the release of the generic version of Neurontin in 2004, the drug had racked up a whopping $2.7 billion in sales in just one year (2003)! During this marketing push, the company alleged that the product was also effective in the treatment of pain and migraines. But the clinical studies did not support this claim. Naturally, Pfizer has denied these allegations. But the company already pleaded guilty and paid $430 million in fines and damages for illegally marketing Neurontin back in 2004. So why should we believe they're not to blame in this latest case? William Campbell Douglass II, M.D. **************Get the Moviefone Toolbar. Showtimes, theaters, movie news & more!(http://pr.atwola.com/promoclk/100000075x1212774565x1200812037/aol?redir=htt p://toolbar.aol.com/moviefone/download.html?ncid=emlcntusdown00000001)
